Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury

Hypertension

Volumn 42, Issue 1, 2003, Pages 31-38

  Shao, Jing ^a   Nangaku, Masaomi ^a   Miyata, Toshio ^b   Inagi, Reiko ^b   Yamada, Koei ^a   Kurokawa, Kiyoshi ^b   Fujita, Toshiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin; Angiotensin II type 1 receptor blocker; Cytokines; Helper T cell; Tubulointerstitial damage

Indexed keywords

ALPHA ACTIN; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CYTOKINE; GAMMA INTERFERON; HYDRALAZINE; INTERLEUKIN 4; OLMESARTAN; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; IMIDAZOLE DERIVATIVE; MESSENGER RNA; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CELL LOSS; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPERTENSION; INTERSTITIAL NEPHRITIS; KIDNEY; KIDNEY FUNCTION; KIDNEY INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE; SPLEEN; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; T LYMPHOCYTE; TH1 CELL; ANIMAL; BIOSYNTHESIS; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HELPER CELL; IMMUNOLOGY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION; WISTAR RAT;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; CYTOKINES; HYPERTENSION; IMIDAZOLES; INTERFERON TYPE II; INTERLEUKIN-4; KIDNEY; MALE; NEPHRITIS, INTERSTITIAL; POLYMERASE CHAIN REACTION; PROTEINURIA; RATS; RATS, WISTAR; RECEPTORS, ANGIOTENSIN; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TETRAZOLES;

EID: 0038480717     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000075082.06183.4E     Document Type: Article

References (49)

1. de Zeeuw D. Can angiotensin II be used for renoprotection? Kidney Int. 2002;61:1176-1177.
2. Dzau VJ. Theodore Cooper Lecture: tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension. 2001;37:1047-1052.
3. Meister B, Lippoldt A, Bunnemann B, Inagami T, Ganten D, Fuxe K. Cellular expression of angiotensin type-1 receptor mRNA in the kidney. Kidney Int. 1993;44:331-336.
4. Zhuo J. Song K, Harris PJ, Medelson FA. In vitro autoradiography reveals predominantly ATI angiotensin II receptors in rat kidney. Renal Physiol Biochem. 1992;15:231-239.
5. Morrissey JJ. Angiotensin II: an immune costimulator? Am J Kidney Dis. 2000;36:434-440.
6. Oikawa T, Freeman M, Lo W, Vaughan DE, Fogo A. Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. Kidney Int. 1997;51:164-172.
7. Moulder JE, Fish BL, Cohen EP, Bonsib SM. Angiotensin II receptor antagonists in the prevention of radiation nephropathy. Radiat Res. 1996;146:106-110.
8. Furukawa Y, Matsumotori A, Hirozane T, Sasayama S. Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. Circulation. 1996;93:333-339.
9. Tanaka A, Matsumori A, Wang W, Sasayama S. Angiotensin II receptor antagonist reduces myocardial damage in an animal model of myocarditis. Circulation. 1996;90:2051-2055.
10. Amuchastegui S, Azzolini SC, Mister M, Pezzotta A, Perico N, Remuzzi G. Chronic allograft nephropathy in the rat is improved by angiotensin II receptor blockade but not by calcium channel antagonism. J Am Soc Nephrol. 1998:9:1948-1955.
11. Benedikrsson H, Chea R, Davidoff A, Paul L. Antihypertensive drug treatment in chronic renal allograft rejection in the rat: effect on structure. Transplantation. 1996;62:1634-1642.
12. Mackenzie HS, Ziai F, Nagano H, Azuma H, Troy JL, Rennke HG, Tilney NL, Brenner BM. Candesartan cilexetil reduces chronic renal allograft injury in Fisher 224 Lewis rats. J Hypertens. 1997;15(suppl):S21-S25.
13. Hisada Y, Sugaya T, Yamanouchi M, Uchida H, Fujimura H, Sakurai H, Fukamizu A, Murakami K. Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest. 1999;103:627-635.
14. Rodriguez-Iturbe B, Pons H, Herrera-Acosta J, Johnson RJ. Role of immunocompetent cells in nonimmune renal diseases. Kidney Int. 2001;59:1626-1640.
15. Nataraj C, Oliverio MI, Mannon RB, Mannon PJ, Audoly LP, Amuchastegui CS, Ruiz P, Smithies O, Coffman TM. Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. J Clin Invest. 1999;104:1693-1701.
16. Cunard R, Kelly CJ. T cells and minimal change disease. J Am Soc Nephrol. 2002;13:1409-1411.
17. Meyers CM, Kelly CJ. Effector mechanisms in organ-specific autoimmunity. I. Characterization of a CD8+ T cell line that mediates murine interstitial nephritis. J Clin Invest. 1991;88:408-416.
18. Rennke HG, Klein PS, Sandstrom DJ, Mendrick DL. Cell-mediated immune injury in the kidney: acute nephritis induced in the rat by azobenzene arsenate. Kidney Int. 1994;45:1044-1056.
19. Li S, Holdsworth SR, Tipping PG. Antibody independent crescentic glomerulonephritis in mu chain deficient mice. Kidney Int. 1997;51:672-678.
20. Mosmann TR, Coffman RL. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol. 1989;46:111-147.
21. Kelly CJ. Development and expression of nephritogenic T cells. In: Nelson EG, Couser WG, eds. Immunologic Renal Disease. Philadelphia, Pa: Lippincott-Raven Publishers; 1997:251-263.
22. Fernandez-Castelo S, Arzt ES, Pesce A, Criscuolo ME, Diaz A, Finkielman S, Nahmod VE. Angiotensin II regulates interferon-γ production. J Interferon Res. 1987;7:261-268.
23. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Floege J, Schwartz SM. Renal injury from angiotensin II-mediated hypertension. Hypertension. 1992;19:464-474.
24. Lombardi DM, Viswanathan M, Vio CP, Saavedra JM, Schartz SM, Johnson RJ. Renal and vascular injury induced by exogenous angiotensin II is AT1 receptor-dependent. Nephron. 2001;87:66-74.
25. Lombardi D, Gordon KL, Polinsky K, Suga S, Schwartz SM, Johnson RJ. Salt-sensitive hypertension develops after short-term exposure to angiotensin II. Hypertension. 1999;33:1013-1019.
26. Ishisaka N, Aizawa T, Yamazaki I, Usui S, Mori I, Kurokawa K, Tang SS, Ingelfinger JR, Ohno M, Nagai R. Abnormal iron deposition in renal cells in the rat with chronic angiotensin II administration. Lab Invest. 2002;82:87-96.
27. Zamauskaite A, Perez-Cruz I, Yaqoob M, Madrigal A, Cohen S. Effect of renal dialysis therapy modality on T cell cytokine production. Nephrol Dial Transplant. 1999;14:49-55.
28. Morokata T, Ishikawa J, Ida K, Yamada T. C57BL/6 mice are more susceptible to antigen-induced pulmonary eosinophilia than BALB/c mice, irrespective of systemic T helper 1/T helper 2 responses. Immunology. 1999;98:345-351.
29. Suzuki Y. Gomez-Guerrero C, Shirato I, Lopez-Franco O, Hernandez-Vargas P, Sanjuan G, Ruiz-Ortega M, Sugaya T, Okumura K, Tomino Y, Ra C, Egido J. Susceptibility to T cell-mediated injury in immune complex disease is linked to local activation of renin-angiotensin system: the role of NF-AT pathway. J Immunol. 2002;169:4136-4146.
30. Wolf G, Wenzel U, Burns KD, Harris RC, Stahl RA, Thaiss F. Angiotensin II activates nuclear transcription factor-κB through AT1 and AT2 receptors. Kidney Int. 2002;61:1986-1995.
31. 2 through a PKC-dependent pathway. J Am Soc Nephrol. 2002;13:1179-1189.
32. Bailey T, Stark S, Grant A, Hartnett C, Tsang M, Kalyuzhny A. A multidonor ELISPOT study of IL-1β, IL-2, IL-4, IL-6, IL-13, IFN-γ, and TNF-α release by cryopreserved human peripheral blood mononuclear cells. J Immunol Methods. 2002;270:171-182.
33. Yi Q, Desikan R, Barlogie B, Munshi N. Optimizing dendritic cell-based immunotherapy in multiple myeloma. Br J Haematol. 2002;117:297-305.
34. Shao J, Miyata T, Yamada K, Hanafusa N, Wada T, Gordon KL, Inagi R, Kurokawa K, Fujita T, Johnson RJ, Nangaku M. Protective role of nitric oxide in a model of thrombotic microangiopathy in rats. J Am Soc Nephrol. 2001;12:2088-2097.
35. Iruela-Arispe L, Gordon K, Hugo C, Duijvestijn AM, Claffey KP, Reilly M, Couser WG, Alpers CE, Johnson RJ. Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis. Am J Pathol. 1995;147:1715-1727.
36. Nangaku M, Alpers CE, Pippin J, Shankland SJ, Kurokawa K, Alder S, Morgan BP, Johnson RJ, Couse WG. CD59 protects glomerular endothelial cells from immune-mediated thrombotic microangiopathy in rats. J Am Soc Nephrol. 1998;9:590-597.
37. Wüthrich RP, Singer GG, Kelley VR. Antigen presentation by renal parenchyma. In: Nelson EG, Couser WG, eds. Immunologic Renal Disease. Philadelphia, Pa: Lippincott-Raven Publishers; 1997:193-202.
38. Paul W, Seder R. Lymphocyte responses and cytokines. Cell. 1994;76:241-251.
39. Nikolic-Paterson DJ, Lan HY, Atkins RC. Macrophages in immune renal injury. In: Nelson EG, Couser WG, eds. Immunologic Renal Disease. Philadelphia, Pa: Lippincott-Raven Publishers; 1997:575-592.
40. Tang WW, Qi M, Warren JS. Monocyte chemoattractant protein 1 mediates glomerular macrophage infiltration in anti-GBM Ab GN. Kidney Int. 1996;50:665-671.
41. Haag-Weber M, Horl WH. The immune system in uremia and during its treatment. New Horizons. 1995;3:669-679.
42. Girndt M, Sester M, Sester U, Kaul H, Kohler H. Molecular aspects of T-and B-cell function in uremia. Kidney Int Suppl. 2001;59(S78):S206-S211.
43. Nelson J, Ormrod DJ, Wilson D, Miller TE. Host immune status in uraemia, III: humoral response to selected antigens in the rat. Clin Exp Immunol. 1980;42:234-240.
44. Lewin E, Ladefoged J, Brandi L, Olgaard K. Parathyroid hormone dependent T cell proliferation in uremic rats. Kidney Int. 1993;44:379-384.
45. Donati D, Degiannis D, Raskova J, Raska K Jr. Uremic serum effects on peripheral blood mononuclear cell and purified T lymphocyte responses. Kidney Int. 1992;42:681-689.
46. Prado EB, Cabrera WH, Nicastri AL, Prado MJ, Leo P, Marcondes M, Siqueira M, Iabanez OC. Reduced humoral immunity in uremic mice genetically selected for high antibody response. Braz J Med Biol Res. 1995;28:1081-1087.
47. Maldonado-Lopez R, Moser M. Dendritic cell subsets and the regulation of Th1/Th2 responses. Semin Immunol. 2001;13:275-282.
48. Moser M, Murphy KM. Dendritic cell regulation of TH1-TH2 development. Nat Immunol. 2000;1:199-205.
49. Tsutsumi K, Stromberg C, Saavedra J. Characterization of angiotensin II receptor subtypes in the rat spleen. Peptides. 1992;13:291-296.